Technologies – Innovita Research
TechnologiesTechnologiesTechnologiesTechnologies
  • Home
  • Company
    • Our Vision
    • History
    • Current State
    • Contact
  • R&D Projects
    • Anti aging research
    • Mitochondrial transfer technology
    • Anticancer vaccine research
  • Technologies
    • Cancer Immunotherapy
    • Autoimmune and Allergic Disorders Immunotherapy
    • Chronic Inflammatory Diseases Immunotherapy
    • OPI Therapy for Motor and Skin Diseases
    • Storage of Immune Cells
  • R&D Products
    • Cord blood plasma
    • Mesenchymal Stem Cells
    • Exosomes
    • Polyantigenic anticancer vaccine
    • Cell lines
    • Cell-based Products
  • Clinic
  • EU projects
  • News
✕

Technologies

  • Home
  • Technologies

Innovita Research has developed some experimental technologies that can be provided for scientific and other customers. In many cases we can help with the preparation and application of these technologies under customer local governmental rules/requirements.

  • Cancer immunotherapy
  • T-cell immunotherapy (T-cell vaccination) for autoimmune and allergic disorders
  • Adoptive cell-based immunotherapy for chronic inflammatory diseases
  • OPI therapy for motor and skin diseases
  • Storage of immune cells

Related science news

  • Upgraded tumor model optimizes search for cancer therapies
    March 21, 2023
  • Can synthetic polymers replace the body’s natural proteins?
    March 21, 2023
  • Spinal cord stimulation may restore arm and hand mobility after stroke
    March 19, 2023
  • Scientists reveal a potential new approach to treating liver cancer
    March 19, 2023
  • Scientists unravel the effects of new medication for advanced melanoma with the help of AI
    March 19, 2023
More news.
© 2017 - 2023 Innovita Research | Privacy policy